journal article·2018-09-01Open access

An Automatic Analysis System for High-Throughput Clostridium Difficile Toxin Activity Screening

Megan Garland, Joanna Jaworek-Korjakowska, Urszula Libal, Matthew Bogyo, Marcin Sieńczyk

Applied Sciences· Volume 8· Issue 9

Abstract

Clostridium difficile infection (CDI) is an increasing global health threat and major worldwide cause of hospital-acquired diarrhea. The development of novel therapies to effectively treat this bacterial pathogen is an unmet clinical need. Here, we describe an image processing and classification algorithm that automatically identifies toxin-induced cytotoxicity to host cells based on characteristic morphological changes. This efficient and automatic algorithm can be incorporated into a screening platform to identify novel anti-toxin inhibitors of the C. difficile major virulence factors TcdA and TcdB, and contains the following steps: image enhancement, cell segmentation, and classification. We tested the algorithm on 504 images (containing 5096 cells) and achieved 93% sensitivity and 91% specificity, indicating that the proposed computational approach correctly classified most of the cells and provided reliable information for an effective screening platform. This algorithm achieved higher classification results compared to existing cell counter and analysis programs, scoring 92.6% accuracy. Compared to visual examination by a researcher, the algorithm significantly decreased classification time and identified toxin-induced cytotoxicity in an unbiased manner. Availability: Examples are available at home.agh.edu.pl/jaworek/CDI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Clostridium difficile and Clostridium perfringens research · Antimicrobial Resistance in Staphylococcus · Bacterial Identification and Susceptibility Testing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cancer Biology Program, Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA

Department of Automatic Control and Robotics, AGH University of Science and Technology, 30-059 Krakow, Poland

Signal Processing Systems Department, Faculty of Electronics, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland

Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA

Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA

Faculty of Chemistry, Division of Medicinal Chemistry and Microbiology, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland

References (51)

Show source-provided references
1. Biology of Clostridium difficile: Implications for epidemiology and diagnosis10.1146/annurev-micro-090110-102824 ↗
2. Goudarzi, M., Seyedjavadi, S.S., Goudarzi, H., Mehdizadeh Aghdam, E., and Nazeri, S. (2014). Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica, 2014.10.1155/2014/916826 ↗
3. Multistate point-prevalence survey of health care-associated infections10.1056/NEJMoa1306801 ↗
4. Discovery and preclinical development of new antibiotics10.3109/03009734.2014.896437 ↗
5. Meeting the societal need for new antibiotics: The challenges for the pharmaceutical industry10.1111/bcp.12401 ↗
6. Toward a structural understanding of Clostridium difficile toxins A and B10.3389/fcimb.2012.00028 ↗
7. Centers for Disease Control and Prevention (2018, August 22). QuickStats: Rates of Clostridium Difficile Infection among Hospitalized Patients Aged ≥65 Years,* by Age Group—National Hospital Discharge Survey, United States, 1996–2009, Available online: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a7.htm.
8. Clostridium difficile colitis: pathogenesis and host defence10.1038/nrmicro.2016.108 ↗
9. Clostridium difficile Infection: New Insights Into Management10.1016/j.mayocp.2012.07.016 ↗
10. For the Polymer Alternative for CDI Treatment (PACT) Investigators. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: Results from two multinational, randomized, controlled trials10.1093/cid/ciu313 ↗
11. Can we identify patients at high risk of recurrent Clostridium difficile infection?10.1111/1469-0691.12046 ↗
12. Chemical Strategies To Target Bacterial Virulence10.1021/acs.chemrev.6b00676 ↗
13. Inhibiting Microbial Toxins Using Plant-Derived Compounds and Plant Extracts10.3390/medicines2030186 ↗
14. Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A10.1056/NEJM200002103420604 ↗
15. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea10.1016/S0140-6736(97)08062-8 ↗
16. Clostridium difficile toxins: Mediators of inflammation10.1159/000332946 ↗
17. Bender, K.O., Garland, M., Ferreyra, J.A., Hryckowian, A.J., Child, M.A., Puri, A.W., Solow-Cordero, D.E., Higginbottom, S.K., Segal, E., and Banaei, N. (2015). A small-molecule antivirulence agent for treating Clostridium difficile infection. Sci. Transl. Med., 7.10.1126/scitranslmed.aac9103 ↗
18. Lacy, D.B. (2018, August 22). Pre-Clinical Evaluation of Clostridium Difficile Toxin Inhibitors. Available online: http://grantome.com/grant/NIH/I01-BX002943-01.
19. Larabee, J.L., Bland, S.J., Hunt, J.J., and Ballard, J.D. (2017). Intrinsic toxin-derived peptides destabilize and inactivate Clostridium difficile TcdB. MBio, 8.10.1128/mBio.00503-17 ↗
20. Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB)10.1016/j.bmcl.2018.01.005 ↗
21. Small Molecule Inhibitors of Clostridium difficile Toxin B-Induced Cellular Damage10.1016/j.chembiol.2014.12.010 ↗
22. An open-source computational tool to automatically quantify immunolabeled retinal ganglion cells10.1016/j.exer.2016.04.012 ↗
23. Fiji: An open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
24. The ImageJ ecosystem: An open platform for biomedical image analysis10.1002/mrd.22489 ↗
25. NIH Image to ImageJ: 25 years of image analysis10.1038/nmeth.2089 ↗
26. Chaumont, F. (2018, August 22). Manual Counting: Documentation. Available online: www.icy.bioimageanalysis.org/plugin/Manual_Counting.
27. Efficacy of ImageJ in the assessment of apoptosis10.1186/1746-1596-7-15 ↗
28. Brocher, J., and Wagner, T. (2018, August 22). BioVoxxel Toolbox (ImageJ/Fiji). Available online: www.biovoxxel.de.
29. A multi-scale 3D Otsu thresholding algorithm for medical image segmentation10.1016/j.dsp.2016.08.003 ↗
30. Topographic distance and watershed lines10.1016/0165-1684(94)90060-4 ↗
31. A watershed approach for improving medical image segmentation10.1080/10255842.2012.666794 ↗
32. Hastie, T., Tibshirani, R., and Friedman, J.H. (2009). The Elements of Statistical Learning: Data Mining, Inference, and Prediction, Springer. [2nd ed.].10.1007/978-0-387-84858-7 ↗
33. Japkowicz, N., and Shah, M. (2011). Evaluating Learning Algorithms: A Classification Perspective, Cambridge University Press.10.1017/CBO9780511921803 ↗
34. Bishop, C.M. (2006). Pattern Recognition and Machine Learning, Springer.
35. Devroye, L., Gyorfi, L., and Lugosi, G. (1996). A Probabilistic Theory of Pattern Recognition, Springer.10.1007/978-1-4612-0711-5 ↗
36. Duda, R.O., Hart, P.E., and Stork, D.G. (2000). Pattern Classification, Wiley. [2nd ed.].
37. Mitchell, T. (1997). Machine Learning, McGraw Hill.
38. Webb, A.R., and Copsey, K.D. (2011). Statistical Pattern Recognition, Wiley. [3rd ed.].10.1002/9781119952954 ↗
39. Medical data classification with Naïve Bayes approach10.3923/itj.2012.1166.1174 ↗
40. John, G.H., and Langley, P. (1995, January 18–20). Estimating continuous distributions in bayesian classifiers. Proceedings of the 11th Conference on Uncertainty in Artificial Intelligence, Montreal, QC, Canada.
41. Naïve Multi-label Classification of YouTube Comments Using Comparative Opinion Mining10.1016/j.procs.2016.04.009 ↗
42. Fast Gaussian Naïve Bayes for searchlight classification analysis10.1016/j.neuroimage.2017.09.001 ↗
43. Predictive Modelling of Seismic Hazard Applying Naïve Bayes and Granular Computing Classifiers10.1016/j.proenv.2015.05.022 ↗
44. Vangelis, M., Ion, A., and Geogios, P. Spam Filtering with Naïve Bayes—Which Naïve Bayes? In Proceedings of the 3rd Conference on Email and Anti-Spam, Mountain View, CA, USA, 27–28 July 2006.
45. Sample size estimation in diagnostic test studies of biomedical informatics10.1016/j.jbi.2014.02.013 ↗
46. An Introduction to ROC Analysis10.1016/j.patrec.2005.10.010 ↗
47. A comparison of confidence/credible interval methods for the area under the ROC curve for continuous diagnostic tests with small sample size10.1177/0962280215602040 ↗
48. Incorporating receiver operating characteristics into naive Bayes for unbalanced data classification10.1007/s00607-016-0483-z ↗
49. An experimental comparison of cross-validation techniques for estimating the area under the ROC curve10.1016/j.csda.2010.11.018 ↗
50. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph10.1016/0022-2496(75)90001-2 ↗
51. Cortes, C., and Mohri, M. (2004). AUC optimization vs. error rate minimization. Advances in Neural Information Processing Systems, MIT Press.